Follow-up survey for comparing stable dosing with a symptom based as needed-regimen” in moderate and severe persitent asthma.

GlaxoSmithKline AB0 个研究点开始时间: 2008年10月23日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•Males and females using combination treatment with inhaled corticosteroids and long-acting beta-agonists (Seretide) following a regular stable dosing regimen or patients using a similar combination treatment (Symbicort) but following a symptom based as needed” regimen”. To be included in the study, patients must have been prescribed to take medicines in any of these two regimens. No changes will be made to the treatments in the study. Subjects must have given written informed consent to participate in the study at visit 1. Subjects must be able to understand and complete daily diary card during three months, able to complete quality of life questionnaires and able to use a PEF-meter. Subjects must be able to attend a visit to the clinic three months after visit 1.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Poor compliance completing the daily diary card and/or the quality of life questionnaires.

发起方